Leukemia Research
Volume 28, Issue 8 , Pages 869-877 , August 2004

Induction of CD28 on the new myeloma cell line MOLP-8 with t(11;14)(q13;q32) expressing δ/λ type immunoglobulin

  • Yoshinobu Matsuo

      Affiliations

    • Fujisaki Cell Center, Hayashibara Biochemical Labs., Inc., 675-1 Fujisaki, Okayama 702-8006, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81-86-276-8621; fax: +81-86-274-2150.
    • ,
  • Hans G Drexler

      Affiliations

    • DSMZ-German Collection of Microorganisms and Cell Cultures, Braunschweig, Germany
    • ,
  • Akira Harashima

      Affiliations

    • Fujisaki Cell Center, Hayashibara Biochemical Labs., Inc., 675-1 Fujisaki, Okayama 702-8006, Japan
    • ,
  • Ayumi Okochi

      Affiliations

    • Fujisaki Cell Center, Hayashibara Biochemical Labs., Inc., 675-1 Fujisaki, Okayama 702-8006, Japan
    • ,
  • Atsuhiko Hasegawa

      Affiliations

    • Department of 1st Internal Medicine, Ehime University School of Medicine, Shigenobu, Ehime, Japan
    • ,
  • Kensuke Kojima

      Affiliations

    • Department of 1st Internal Medicine, Ehime University School of Medicine, Shigenobu, Ehime, Japan
    • ,
  • Kunzo Orita

      Affiliations

    • Fujisaki Cell Center, Hayashibara Biochemical Labs., Inc., 675-1 Fujisaki, Okayama 702-8006, Japan

Received 31 October 2003 ,Accepted 12 December 2003.

References 

  1. Hallek M, Bergsagel PL, Anderson KC. Multiple myeloma: increasing evidence for a multistep transformation process. Blood. 1998;91:3–21
  2. Klein B, Zhang XG, Lu ZY, Bataille R. Interleukin-6 in human multiple myeloma. Blood. 1995;85:863–872
  3. Matsuoka Y, Moore GE, Yagi Y, Pressman D. Production of free light chains of immunoglobulin by a hematopoietic cell line derived from a patient with multiple myeloma. Proc. Soc. Exp. Biol. Med. 1967;125:1246–1250
  4. Drexler HG, Matsuo Y. Malignant hematopoietic cell lines: in vitro models for the study of multiple myeloma and plasma cell leukemia. Leuk. Res. 2000;24:681–703
  5. Nilsson K. Human B-lymphoid cell lines. Hum. Cell. 1992;5:25–41
  6. Zhang XG, Gaillard JP, Robillard N, Lu ZY, Gu ZJ, Jourdan M, et al.  Reproducible obtaining of human myeloma cell lines as a model for tumor stem cell study in human multiple myeloma. Blood. 1994;83:3654–3663
  7. Robillard N, Jego G, Pellat-Deceunynck C, Pineau D, Puthier D, Mellerin MP, et al.  CD28, a marker associated with tumoral expansion in multiple myeloma. Clin. Cancer Res. 1998;4:1521–1526
  8. Shapiro VS, Mollenauer MN, Weiss A. Endogenous CD28 expressed on myeloma cells up-regulates interleukin-8 production: implications for multiple myeloma progression. Blood. 2001;98:187–193
  9. Matsuo Y, Drexler HG, Nishizaki C, Harashima A, Fukuda S, Kozuka T, et al.  Human bone marrow stroma-dependent myeloma cell line MOLP-5 derived from a patient in leukaemic phase of multiple myeloma. Br. J. Haematol. 2000;109:54–63
  10. F Mitelman, editor. ISCN. An international system for human cytogenetic nomenclature. S Karger, Basel; 1995.
  11. Hopert A, Uphoff CC, Wirth M, Hauser H, Drexler HG. Specificity and sensitivity of polymerase chain reaction (PCR) in comparison with other methods for the detection of mycoplasma contamination in cell lines. J. Immunol. Methods. 1993;164:91–100
  12. Ambinder RF, Lambe BC, Mann RB, Hayward SD, Zehnbauer BA, Burns WS, et al.  Oligonucleotides for polymerase chain reaction amplification and hybridization detection of Epstein–Barr virus DNA in clinical specimens. Mol. Cell Probes. 1990;4:397–407
  13. Matsuo Y, Nishizaki C, Drexler HG. Efficient DNA fingerprinting method for the identification of cross-culture contamination of cell lines. Hum. Cell. 1999;12:149–154
  14. Gould J, Alexanian R, Goodacre A, Pathak S, Hecht B, Barlogie B. Plasma cell karyotype in multiple myeloma. Blood. 1988;71:453–456
  15. Ohtsuki T, Yawata Y, Wada H, Sugihara T, Mori M, Namba M. Two human myeloma cell lines, amylase-producing KMS-12-PE and amylase-non-producing KMS-12-B.M., were established from a patient, having the same chromosome marker, t(1114)(q13q32). Br. J. Haematol. 1989;73:199–204
  16. Tsujimoto Y, Yunis J, Onorato-Showe L, Erikson J, Nowell PC, Croce CM. Molecular cloning of the chromosomal break point of B-cell lymphomas and leukemias with t(11; 14) chromosome translocation. Science. 1984;224:1403–1406
  17. Withers DA, Harvey RC, Faust JB, Melnyk O, Carey K, Meeker TC. Characterization of a candidate bcl-1 gene. Mol. Cell Biol. 1991;10:4846–4853
  18. Drexler HG, MacLeod RA. Malignant hematopoietic cell lines: in vitro models for the study of mantle cell lymphoma. Leuk. Res. 2002;26:781–787
  19. Barlogie B, Epstein J, Selvanayagam P, Alexanian R. Plasma cell myeloma: new biological insights and advances in therapy. Blood. 1989;73:865–879
  20. Shimizu S, Yoshioka R, Hirose Y, Sugai S, Tachibana J, Konda S. Establishment of two interleukin 6 (B cell stimulatory factor 2/interferon beta 2)-dependent human bone marrow-derived myeloma cell lines. J. Exp. Med. 1989;169:339–344
  21. Kubonishi I, Seto M, Shimamura T, Enzan H, Miyoshi I. The establishment of an interleukin-6-dependent myeloma cell line (FLAM-76) carrying t(11; 14)(q13; q32) chromosome abnormality from an aggressive non-secretory plasma cell leukemia. Cancer. 1992;70:1528–1535
  22. Goto H, Shimazaki C, Tatsumi T, Yamagata N, Fujita N, Tsuchiya M, et al.  Establishment of a novel myeloma cell line KPMM2 carrying t(3; 14)(q21; q32), which proliferates specifically in response to interleukin-6 through an autocrine mechanism. Leukemia. 1995;9:711–718
  23. Manabe A, Murti KG, Coustan-Smith E, Kumagai M, Behm FG, Raimondi SC, et al.  Adhesion-dependent survival of normal and leukemic human B lymphoblasts on bone marrow stromal cells. Blood. 1994;83:758–766
  24. Merville P, Dechanet J, Desmouliere A, Durand I, De Bouteiller O, Garrone P, et al.  Bcl-2+ tonsillar plasma cells are rescued from apoptosis by bone marrow fibroblasts. J. Exp. Med. 1996;183:227–236
  25. Cook G, Dumber M, Franklin IM. The role of adhesion molecules in multiple myeloma. Acta Haematol. 1997;97:81–89
  26. Ridley RC, Xiao H, Hata H, Woodliff J, Epstein J, Sanderson RD. Expression of syndecan regulates human myeloma plasma cells adhesion to type I collagen. Blood. 1993;81:767–774
  27. Harashima A, Matsuo Y, Nishizaki C, Kozuka T, Fukuda S, Sezaki T, et al.  Human bone marrow stroma-dependent myeloma sister cell lines MOLP-6 and MOLP-7 derived from a patient with multiple myeloma. Hum. Cell. 2000;13:43–54
  28. Kozbor D, Moretta A, Messner HA, Moretta L, Croce CM. Tp44 molecules involved in antigen-independent T-cell activation are expressed on human plasma cells. J. Immunol. 1987;138:4128–4132
  29. Pellat-Deceunynck C, Bataille R, Robillard N, Harousseau J-L, Rapp M-J, Juge-Morineau N, et al.  Expression of CD28 and CD40 in human myeloma cells: a comparative study with normal plasma cells. Blood. 1994;84:2597–2603
  30. Zhang XG, Olive D, Devos J, Rebouissou C, Ghitto-Ragueneau M, Ferlin M, et al.  Malignant plasma cell lines express a functional CD28 molecule. Leukemia. 1998;12:610–618
  31. Matsuzaki H, Hata H, Takeya M, Takatsuki K. Establishment and characterization of an amylase-producing human myeloma cell line. Blood. 1988;72:978–982
  32. Taylor JJ. Hypercalcaemia in “non-secretory” myeloma. Haematologia. 1986;19:269–273
  33. Fine P, Adler K, Gerstenfeld D. Idiopathic hyperammonemia after high-dose chemotherapy. Am. J. Med. 1989;86:629
  34. Matsuzaki H, Hata H, Sonoki T, Matsuno F, Kuribayashi N, Yoshida M, et al.  Serum amino acid disturbance in multiple myeloma with hyperammonemia. Int. J. Hematol. 1995;61:131–137
  35. Otsuki T, Yamada O, Sakaguchi H, Ichiki T, Kouguchi K, Wada H, et al.  In vitro excess ammonia production in human myeloma cell lines. Leukemia. 1998;12:1149–1158
  36. Otsuki T, Nakazawa N, Taniwaki M, Yamada O, Sakaguchi H, Wada H, et al.  Establishment of a new human myeloma cell line, KMS-18, having t(4; 14)(p16.3; q32.3) derived from a case phenotypically transformed from Ig A-lambda to BJP-lambda, and associated with hyperammonemia. Int. J. Oncol. 1998;12:545–552
  37. Matsuzaki H, Matsuno F, Yoshida M, Hata H, Okazaki K, Takatsuki K. Human myeloma cell line (KHM-4) established from a patient with multiple myeloma associated with hyperammonemia. Intern. Med. 1992;31:339–343

PII: S0145-2126(03)00422-3

doi: 10.1016/j.leukres.2003.12.008

Leukemia Research
Volume 28, Issue 8 , Pages 869-877 , August 2004

Article Tools

* Image Usage & Resolution